Federated Hermes, Inc. Tg Therapeutics, Inc. Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

A detailed history of Federated Hermes, Inc. transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 103,801 shares of TGTX stock, worth $3.48 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

103,801

Previous 50 207502.0%

Holding current value

$3.48 Million

Previous $0 Infinity%

% of portfolio

0.01%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$17.21 - $25.28 $1.79 Million - $2.62 Million	103,751 Added 207502.0%	103,801 $2.43 Million
Q2 2024 Aug 08, 2024	BUY	$13.32 - $19.19 $666 - $959	50 New	50 $0
Q3 2023 Nov 13, 2023	SELL	$8.36 - $26.5 $1,128 - $3,577	-135 Reduced 71.05%	55 $0
Q2 2023 Aug 14, 2023	BUY	$15.48 - $35.0 $15 - $35	1 Added 0.53%	190 $4,000
Q1 2023 May 08, 2023	SELL	$10.23 - $19.34 $4,051 - $7,658	-396 Reduced 67.69%	189 $2,000
Q4 2022 Feb 13, 2023	SELL	$5.01 - $11.83 $2.91 Million - $6.88 Million	-581,836 Reduced 99.9%	585 $6,000
Q3 2022 Nov 14, 2022	SELL	$4.57 - $8.4 $7.55 Million - $13.9 Million	-1,652,558 Reduced 73.94%	582,421 $3.45 Million
Q2 2022 Aug 15, 2022	BUY	$3.74 - $10.66 $5.43 Million - $15.5 Million	1,452,446 Added 185.61%	2,234,979 $9.5 Million
Q1 2022 May 13, 2022	BUY	$7.81 - $20.45 $6.11 Million - $16 Million	782,533 New	782,533 $7.44 Million
Q1 2021 May 13, 2021	SELL	$41.61 - $54.3 $256,858 - $335,193	-6,173 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$25.27 - $54.9 $896,554 - $1.95 Million	-35,479 Reduced 85.18%	6,173 $321,000
Q3 2020 Nov 12, 2020	SELL	$18.49 - $27.24 $6.59 Million - $9.71 Million	-356,356 Reduced 89.53%	41,652 $1.12 Million
Q2 2020 Aug 13, 2020	BUY	$8.9 - $21.84 $2.71 Million - $6.66 Million	304,957 Added 327.73%	398,008 $7.75 Million
Q1 2020 May 13, 2020	BUY	$7.14 - $15.99 $662,956 - $1.48 Million	92,851 Added 46425.5%	93,051 $916,000
Q4 2019 Feb 14, 2020	BUY	$5.1 - $11.2 $1,019 - $2,240	200 New	200 $2,000
Q3 2018 Nov 13, 2018	SELL	$5.15 - $14.0 $384,411 - $1.05 Million	-74,643 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$12.5 - $15.0 $213,800 - $256,560	17,104 Added 29.73%	74,643 $982,000
Q1 2018 May 09, 2018	BUY	$8.7 - $16.8 $500,589 - $966,655	57,539 New	57,539 $817,000

Others Institutions Holding TGTX

# of Institutions

339

Shares Held

88.5M

Call Options Held

2.35M

Put Options Held

1.7M

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.88B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Tg Therapeutics, Inc. Transaction History